Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?

Prostate cancer (PCa) is a highly prevalent malignancy and constitutes a major cause of cancer-related morbidity and mortality. It emerges through the acquisition of genetic and epigenetic alterations. Epigenetic modifications include DNA methylation, histone modifications and microRNA deregulation....

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Pedro Bargão, Patel, Hitendra, Henrique, Rui, Félix, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046922/
https://www.ncbi.nlm.nih.gov/pubmed/32133274
http://dx.doi.org/10.5306/wjco.v11.i2.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046922/
https://www.ncbi.nlm.nih.gov/pubmed/32133274
http://dx.doi.org/10.5306/wjco.v11.i2.43

Ejemplares similares